Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
9.56
-0.27 (-2.75%)
Apr 29, 2026, 3:00 PM CST
28.84%
Market Cap 19.10B
Revenue (ttm) 2.95B
Net Income (ttm) 1.22B
Shares Out 1.94B
EPS (ttm) 0.62
PE Ratio 15.85
Forward PE 27.98
Dividend 0.30 (3.05%)
Ex-Dividend Date Jun 25, 2025
Volume 58,645,410
Average Volume 85,757,302
Open 9.75
Previous Close 9.83
Day's Range 9.30 - 9.76
52-Week Range 7.22 - 10.67
Beta 0.28
RSI 48.43
Earnings Date Apr 20, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.